“Ny kunnskap om blodkreft kan gi mer treffsikker behandling” Inga Kirstine Flaaten Motzfeldt is defending on February 19th 2026 for PhD. degree at the Universitetet of Bergen, with the thesis “Exploration of Disease Mechanisms and Targeted Therapies in Acute Myeloid Leukemia”. The defense is taking place at 12:15–15:00 Location: HUS – BB-bygget, Auditorium 1 The LES MER
Category: News
Poster Prize award: Nicolas Mattias Del Rio Fuenzalida
Congratulations to Nicolas who won the poster prize (2nd place) at the 20th Annual Research Presentations hold by the University of Bergen at Sentralblokka, Haukeland University Hospital, 28–30 January 2026. Poster: Myeloid-Specific Immunomodulatory Profiles Predict Relapse in Patients With Non-metastatic Proximal Colon Cancer. Nicolas Mattias Del Rio Fuenzalida, Kristin Bentung Lygre, Rakel Brendsdal Forthun, Reidun Kristin Kopperud, Pål Tore LES MER
Grant award: The Norwegian Cancer Society
Luiza Ghila and her team in Cell Fate Lab has been awarded funding from The Norwegian Cancer Society’s call “Researcher projects 2025” for the research project “Mapping the bladder tumour immune microenvironment by single cell technologies“. More information is found here: https://chera.w.uib.no/2025/12/grant-award-the-norwegian-cancer-society/
HUVAMER receives Funding from Trond Mohn Foundation
The Trond Mohn Foundation has newly awarded 18 millions NOK to three cancer research projects, one of which is HUVAMER-project “HUVAMER – Home Treatment for Blood Cancer” led by Professor Dr. med. Bjørn Tore Gjertsen. The HUVAMER-project is aimed to test two repurposed drug combinations (hydroxyurea + valproate, and 6-mercaptopurine + valproate) in treatment of LES MER
